Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice. - Wikidata - awgldk - TriplyDB

Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.

Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.

http://www.wikidata.org/entity/Q36667922

about

Modulation of host adaptive immunity by hRSV proteins Protective efficacy and immunogenicity of a combinatory DNA vaccine against Influenza A Virus and the Respiratory Syncytial Virus.Recombinant influenza virus expressing a fusion protein neutralizing epitope of respiratory syncytial virus (RSV) confers protection without vaccine-enhanced RSV disease Recombinant influenza virus carrying the conserved domain of respiratory syncytial virus (RSV) G protein confers protection against RSV without inflammatory disease.A GFP expressing influenza A virus to report in vivo tropism and protection by a matrix protein 2 ectodomain-specific monoclonal antibody.Protection against respiratory syncytial virus by inactivated influenza virus carrying a fusion protein neutralizing epitope in a chimeric hemagglutinin.Aberrant T cell immunity triggered by human Respiratory Syncytial Virus and human Metapneumovirus infection.Structure of the extracellular domain of matrix protein 2 of influenza A virus in complex with a protective monoclonal antibody.A Respiratory Syncytial Virus Vaccine Vectored by a Stable Chimeric and Replication-Deficient Sendai Virus Protects Mice without Inducing Enhanced Disease.Use of chimeric influenza viruses as a novel internal control for diagnostic rRT-PCR assays.Epitope-specific CD4+, but not CD8+, T-cell responses induced by recombinant influenza A viruses protect against Mycobacterium tuberculosis infection.A comparison of RSV and influenza in vitro kinetic parameters reveals differences in infecting time.

P2860

Q27022693-A1484699-8422-448F-A0D3-32ABCB5878A5 Q34964980-8BA78808-BDAB-4A56-89AD-922AE73253C4 Q35070176-BE69B2F2-2EB0-496F-8773-86E4B8194D41 Q35070505-CCEB8B9A-370E-4BE4-A9F0-EFFC5C88F6A3 Q35225083-0866C7F0-4CC6-4507-A885-E6B61648C0A3 Q36739674-BB9A442D-7C10-435C-87DB-03BEF84600BF Q39027049-EEAAB4E5-A96B-4F03-89A6-CD69AB385A2E Q39794523-AED76E7D-4000-41B7-9D40-8D6825976E38 Q40312271-26A5D8C0-991D-4B40-9496-77FB8A05FF3C Q41208292-FAC98159-CC8E-4DF7-A746-7A8EE395A227 Q41645299-7B663247-A4B2-41C3-BF9A-38DCF0FA1B47 Q48506169-12939180-A6A1-4A13-B6AB-12AE3E8EBB8C

P2860

Recombinant influenza virus carrying the respiratory syncytial virus (RSV) F85-93 CTL epitope reduces RSV replication in mice.

http://www.wikidata.org/entity/Q36667922

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

Recombinant influenza virus ca ...... duces RSV replication in mice.

@ast

Recombinant influenza virus ca ...... duces RSV replication in mice.

@en

type

label

Recombinant influenza virus ca ...... duces RSV replication in mice.

@ast

Recombinant influenza virus ca ...... duces RSV replication in mice.

@en

prefLabel

Recombinant influenza virus ca ...... duces RSV replication in mice.

@ast

Recombinant influenza virus ca ...... duces RSV replication in mice.

@en

P1433

Q36667922-26A0A27F-046B-46FF-8524-88ED25073BC4

P1476

Q36667922-71CDC4E4-7A1B-44A4-902A-834C910E0B29

P2093

Q36667922-17393C8E-257F-4AB8-BC80-820DA4D87D58

Q36667922-39F9BAE9-62BC-49A7-ADDA-1D4753C5F39F

Q36667922-3F376B3F-E8B9-443F-A97B-4F729F216E16

Q36667922-53F21FF8-B0A4-4832-8261-63952500ADB4

Q36667922-AA12EAA6-3204-497A-A65F-151139F484D6

Q36667922-AC15576E-160A-4058-9D58-934D3B75A5AF

Q36667922-E07F727C-D347-41A9-96F1-FD8D5945DBE4

Q36667922-EC237D39-203B-4BFA-B3C6-898447F8A465

P2860

Q36667922-08E061C2-326B-46E1-AA07-DF6C2E9E3764

Q36667922-1A48DA8A-562F-4FCB-9D87-20345934506D

Q36667922-28FC8797-0059-4C1D-9F38-EC01BECAF4D7

Q36667922-29CC4338-FCCB-4659-A35C-5A6D9107013B

Q36667922-2CF9EEE6-8BE6-4B5F-835D-FCD879AA3B67

Q36667922-2F62CED9-27F6-4733-AAEC-22AB7788C599

Q36667922-340F1311-36FA-42B8-AA85-BA94EB57CDC5

Q36667922-438853CE-D016-46D8-8DE5-BD356A90BE0E

Q36667922-445F3B28-155D-4491-A06E-13F2F9598B67

Q36667922-4954B39E-B92C-4DCC-9301-907BE46E3C5F

P304

Q36667922-DBA541E6-FD0A-46D7-A8D5-267B032E447D

P31

Q36667922-76ABB18D-5AD5-4E1A-BD34-6F1BBC9C751E

P356

Q36667922-3F69B382-E4B0-4975-B04D-2F6F9CB9F0E3

P407

Q36667922-9D8E89AA-0F68-402D-8F80-0774AAE90D59

P433

Q36667922-27C09263-3A71-4846-9D08-7344CBF60948

P478

Q36667922-92E442DB-F7DD-4A3E-AA3A-9B37E29FBA1D

P577

Q36667922-0175A6CE-2C43-4DAA-8509-054D97F40778

P698

Q36667922-6F58B526-AC75-4D9E-A232-3101B1F10A6C

P932

Q36667922-DD892325-9183-4006-B2F7-FA7BBA82D110

P356

P1433

Journal of Virology

P1476

Recombinant influenza virus ca ...... duces RSV replication in mice.

@en

P2093

Bert Schepens

http://www.w3.org/2001/XMLSchema#string

Kenny Roose

http://www.w3.org/2001/XMLSchema#string

Koen Sedeyn

http://www.w3.org/2001/XMLSchema#string

Michael Schotsaert

http://www.w3.org/2001/XMLSchema#string

Pieter Bogaert

http://www.w3.org/2001/XMLSchema#string

Sarah De Baets

http://www.w3.org/2001/XMLSchema#string

Walter Fiers

http://www.w3.org/2001/XMLSchema#string

Xavier Saelens

http://www.w3.org/2001/XMLSchema#string

P2860

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

Respiratory infections: do we ever recover?

Live attenuated influenza virus vaccines by computer-aided rational design.

Immune responses to influenza virus infection.

Natural and long-lasting cellular immune responses against influenza in the M2e-immune host.

Pulmonary eosinophilia is attenuated by early responding CD8(+) memory T cells in a murine model of RSV vaccine-enhanced disease.

The number of respiratory syncytial virus (RSV)-specific memory CD8 T cells in the lung is critical for their ability to inhibit RSV vaccine-enhanced pulmonary eosinophilia.

Virus-specific CD8+ T lymphocytes downregulate T helper cell type 2 cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection.

Protective T cell immunity against respiratory syncytial virus is efficiently induced by recombinant BCG.

Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses.

P304

3314-3323

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.03019-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

87

http://www.w3.org/2001/XMLSchema#string

P577

2013-01-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23302879

http://www.w3.org/2001/XMLSchema#string

P932

3592148

http://www.w3.org/2001/XMLSchema#string